Compounds > calpain inhibitor 2
Page last updated: 2024-09-03

calpain inhibitor 2 and y 27632

calpain inhibitor 2 has been researched along with y 27632 in 1 studies

Compound Research Comparison

Studies
(calpain inhibitor 2)		Trials
(calpain inhibitor 2)		Recent Studies (post-2010)
(calpain inhibitor 2)		Studies
(y 27632)		Trials
(y 27632)		Recent Studies (post-2010) (y 27632)
680131,9243891

Protein Interaction Comparison

ProteinTaxonomycalpain inhibitor 2 (IC50)y 27632 (IC50)
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain I, cAMP-dependent protein kinase inhibitor alphasynthetic construct6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain I, cAMP-dependent protein kinase inhibitor alphasynthetic construct6
Rho-associated protein kinase 2Homo sapiens (human)0.1942
Ribosomal protein S6 kinase alpha-5Homo sapiens (human)8.3
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)6.1
C-C motif chemokine 2Homo sapiens (human)2.6303
Rho-associated protein kinase 1Homo sapiens (human)0.3713
Serine/threonine-protein kinase N2Homo sapiens (human)0.6
Rho-associated protein kinase 2Bos taurus (cattle)6.1
Rho-associated protein kinase 2Rattus norvegicus (Norway rat)0.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bebawy, M; Luk, F; Roseblade, A; Ung, A1

Other Studies

1 other study(ies) available for calpain inhibitor 2 and y 27632

ArticleYear
Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.
    Current cancer drug targets, 2015, Volume: 15, Issue:3

    Topics: Acrylates; Amides; Antineoplastic Agents; Breast Neoplasms; Calcimycin; Cell Line, Tumor; Cell-Derived Microparticles; Cystamine; Cysteamine; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Oligopeptides; Pantetheine; Pyridines; Verapamil

2015